Risperidone versus haloperidol: I. meta-analysis of efficacy and safety
- 1 January 1998
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (1) , 58-71
- https://doi.org/10.1016/s0149-2918(98)80034-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor bindingPsychopharmacology, 1996
- Antipsychotic and Anxiolytic Properties of Risperidone, Haloperidol, and Methotrimeprazine in Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1996
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Systematic Reviews: Meta-analysis and its problemsBMJ, 1994
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Can meta-analyses be trusted?The Lancet, 1991
- Have You Ever Meta-Analysis You Didn't Like?Annals of Internal Medicine, 1991
- Meta-Analysis in Clinical ResearchAnnals of Internal Medicine, 1987
- MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIAThe Lancet, 1978